Catalent continues expanding clinical supply resources in Asia

Catalent Pharma Solutions has announced the opening of a clinical supply facility, located within its 200,000 sq. ft. cGMP site in Kakegawa, Japan. The site will serve the needs of both domestic and global clinical trial sponsors with services including secondary packaging and labeling, clinical storage, distribution, project management and clinical supply management, and will complement the capabilities of other Catalent facilities in the Asia-Pacific region.

“There is significant demand for Catalent’s clinical supply services in Japan and across the Asia-Pacific region, and we built this facility with our new Demand Led Supply model in mind, to bring customers greater speed and flexibility in their clinical supply chains,” commented Wetteny Joseph, Catalent’s president of Clinical Supply Services.

Late last year, the company announced a quadrupling of capacity at a facility in Shanghai Free Trade Zone, in China, and over the previous year had expanded packaging and refrigerated storage in a Singapore facility. Catalent has additional clinical supply facilities in the US, UK, Germany, Singapore, and China, and an extended network of over 50 audited depots.